Table 1.
Clinical pathological data in the groups with different operation margins
| Factors | ≤ 1 mm | 2~9 mm | ≥ 10 mm | χ 2 | P |
|---|---|---|---|---|---|
|
| |||||
| 108 | 265 | 228 | |||
| Age (>60 years old) | 32 (29.6%) | 76 (28.7%) | 55 (24.1%) | 1706 | 0.426 |
| Gender (Male) | 87 (80.6%) | 230 (86.8%) | 186 (816%) | 3391 | 0184 |
| Preoperation TACE | 19 (17.6%) | 31 (11.7%) | 27 (11.8%) | 2.696 | 0.260 |
| Child-Pugh Grade B | 3 (2.8%) | 16 (6.0%) | 16 (7.0%) | 2.442 | 0.295 |
| Serum AFP>400 ng/ml | 59 (55.7%) | 141 (55.1%) | 123 (55.9%) | 0.034 | 0.983 |
| Patients with cirrhosis | 100 (92.6%) | 236 (89.1%) | 201 (88.2%) | 1.558 | 0.459 |
| Accompanied by portal hypertension | 19 (17.6%) | 47 (17.7%) | 27 (11.8%) | 3.706 | 0.157 |
| Anatomical resection | 25 (23.1%) | 57 (21.5%) | 65 (28.5%) | 3.372 | 0.185 |
| Intraoperative hepatic inflow occlusion | 56 (51.9%) | 157 (59.2%) | 108 (47.4%) | 7.076 | 0.059 |
| operative hemorrhage > 1000 ml | 13 (12.1%) | 46 (17.4%) | 65 (28.7%) | 12.915 | 0.002 |
| Red blood cell transfusion | 31 (28.9%) | 84 (31.7%) | 111 (49.1%) | 14.188 | 0.001 |
| Regional lymph node metastasis | 5 (4.6%) | 5 (1.9%) | 4 (1.8%) | 3.071 | 0.215 |
| Tumor invasion to liver capsule | 77 (71.3%) | 186(70.2%) | 157 (68.9%) | 0.228 | 0.892 |
| With satellite nodules | 14 (13.0%) | 27 (10.2%) | 26 (11.4%) | 0.62 | 0.733 |
| Intrahepatic recurrence | 59 (78.7%) | 131 (49.4%) | 111 (48.7%) | 7.636 | 0.106 |
| Microscopic tumor thrombus | 17 (39.5%) | 23 (34.8%) | 16 (34.8%) | 0.299 | 0.861 |
| ALB | 21 (19.4%) | 34 (12.9%) | 27 (11.9%) | 3.77 | 0.152 |
| ALT | 33 (30.6%) | 63 (23.8%) | 62 (27.2%) | 1.976 | 0.372 |
| CRP | 42 (52.5%) | 89 (58.2%) | 54 (58.7%) | 0.853 | 0.653 |